SciClone Pharmaceuticals Inc. (Nasdaq: SCLN) reported higher third quarter revenue and earnings of 23 cents per diluted share compared with 15 cents per diluted share that surpassed expectations by a wide margin. The stock price leaped $1.67 to close at $9.66.
SciClone beats expectations
November 10, 2015 at 16:22 PM EST
